Reaction
Iris Adhesions reporting signals
As of the last recalculation, Iris Adhesions appears in 499 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is ADALIMUMAB-FKJP (PRR 63.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Adalimumab-Fkjp | 62 | 63.6 | 63.7 |
| Adalimumab-Aaty | 62 | 62.3 | 62.3 |
| Prednisolone Acetate | 14 | 58.0 | 58.1 |
| Adalimumab-Adaz | 62 | 55.8 | 55.9 |
| Timolol | 14 | 49.7 | 49.8 |
| Atropine Sulfate | 12 | 47.5 | 47.5 |
| Brimonidine Tartrate | 19 | 46.2 | 46.3 |
| Atropine | 9 | 46.1 | 46.2 |
| Melphalan | 23 | 44.2 | 44.2 |
| Timolol Maleate | 10 | 42.9 | 43.0 |
| Melphalan Hydrochloride | 24 | 41.9 | 41.9 |
| Brinzolamide | 8 | 39.0 | 39.1 |
| Vemurafenib | 5 | 17.5 | 17.5 |
| Aflibercept | 12 | 16.4 | 16.4 |
| Ranibizumab | 10 | 16.0 | 16.0 |
| Ipilimumab | 14 | 13.9 | 13.9 |